Products & Technology

 

Products & Technology

Precision Biomarker Analysis
Enabling New Insights into the
Biology of Health and Disease

The company’s digital health solution, Simoa, is changing the way in which the biology of health and disease is studied by giving researchers the ability to closely examine critical biomarkers. In doing so, Quanterix enables development of methods to provide much earlier disease detection, better prognoses and enhanced treatment methods and improve the quality of life and longevity of the population for generations to come. The technology is currently being used for applications in a majority of therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. 

Simoa by the Numbers

Number of Scientific Publications
Number of Simoa Assays
Average Simoa LoD (fg/mL)
Average Simoa LoQ (fg/mL)

Latest News

07.12
Alzheimer’s disease is a dangerous and ultimately fatal form of dementia, and according to recent
07.11
Quanterix Corp, Lexington, Mass, has launched the Simoa Neurology 4-Plex A assay (N4PA).
07.11
Published jointly by Quanterix, DestiNA Genomics Ltd., Edinburgh University and the Pfizer-…
07.10
Conducted by the Mayo Clinic, the study looks at whether plasma total tau level can serve as a…